GlassScriptPhysician profile
Hyo Jin Song
NPI 1861771701
$18,906.33
in general payments reported to CMS, 2019-2025
22 companies · $417 in 2025
The $417 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,618 · 2020: $2,337 · 2021: $284 · 2022: $6,227 · 2023: $1,532 · 2024: $5,491 · 2025: $417.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,882 · Travel and Lodging: $2,684 · Consulting Fee: $1,874.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,882.28 |
| Travel and Lodging | $2,683.66 |
| Consulting Fee | $1,874.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $8,702.73 | 2019-2025 | Carto 3, Qdot Micro Catheter |
| Abbott Laboratories | $3,577.08 | 2019-2024 | Aveir, Ensite, Ensite Precision |
| Medtronic Vascular, INC. | $2,247.77 | 2019-2020 | |
| Medtronic, INC. | $1,616.78 | 2022-2025 | Micra, Azure Xt Dr Mri Surescan, Na |
| Boston Scientific Corporation | $927.81 | 2019-2025 | Watchman Flx, Watchman Access System |
| Medical Device Business Services, INC. | $407.88 | 2023 | Carto 3 |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $258.79 | 2020-2025 | Lifevest |
| Abiomed | $172.33 | 2024-2025 | Impella |
| Altathera Pharmaceuticals LLC | $168.90 | 2021 | |
| Janssen Scientific Affairs, LLC | $132.80 | 2024 | Xarelto |
| Heartflow, INC. | $106.57 | 2025 | |
| Janssen Pharmaceuticals, INC | $105.90 | 2020-2023 | Xarelto |
| United Therapeutics Corporation | $100.00 | 2020 | |
| Biotronik INC. | $98.66 | 2019 | |
| Novo Nordisk INC | $59.97 | 2021-2024 | Rybelsus, Ozempic |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.74 | 2020-2023 | Jardiance |
| Novartis Pharmaceuticals Corporation | $41.44 | 2022-2023 | |
| Chiesi USA, INC. | $37.46 | 2019-2020 | |
| Amgen INC. | $35.77 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $20.82 | 2024 | Camzyos |
| Pfizer INC. | $16.46 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $15.67 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hyo Jin Song listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.